NCT03379779

Brief Summary

A prospective observational study. Enrolled participants admitted to ICU due to pneumonia and respiratory failure need mechanical ventilator support. Investigators collected the residual specimens, such as sputum from endotrachea aspiration, bronchoalveolar lavage fluid in those participants as the usual care in the ICU. Those residual samples were sent to extract RNA and sequence by using high-throughput sequencing (next-generation sequencing) method. Investigators will compared the microbiome feature between lower respiratory tract and stool specimens in those participants diagnosed as pneumonia with respiratory failure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 28, 2017

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 20, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

September 16, 2019

Status Verified

September 1, 2019

Enrollment Period

2 years

First QC Date

December 14, 2017

Last Update Submit

September 12, 2019

Conditions

Keywords

MicrobiotaRespiratory FailurePneumoniaLower Respiratory Tract Infection

Outcome Measures

Primary Outcomes (1)

  • The dynamics of the airway bacterial microbiome in the lower respiratory tract specimens in the setting of pneumonia accompanied by respiratory failure at the onset of, and day 3 and day 7 (or before extubation)

    Uses high-throughput sequencing (next-generation sequencing) to sequence the 16S rRNA sequence of bacteria in residual samples

    Compared the dynamic change of mirobiome at the baseline (onset of respiratory failure within 48 hours)m day 3 and day 7

Secondary Outcomes (2)

  • The dynamics of the gut bacterial microbiome in the stool specimens in the setting of pneumonia accompanied by respiratory failure at the onset of, and day 3 and day 7 (or before extubation)

    Compared the dynamic change of mirobiome at the baseline (onset of respiratory failure within 48 hours)m day 3 and day 7

  • The association of the microbiome between lower respiratory tracts and stool specimens in pneumonic patient with respiratory failure

    Compared the association of mirobiome at the baseline (onset of respiratory failure within 48 hours)m day 3 and day 7

Study Arms (1)

Pneumonia patient with respiratory failure

Sputum and stool sampling day 1, 3 and 7 after enrolling into study

Diagnostic Test: 16s RNA sequence of sputum, bronchoalveolar lavage fluid (options), stool

Interventions

We will check the microbiome in lower respiratory samples (sputum and bronchoalveolar lavage fluid) and stool by using 16S RNA sequencing

Pneumonia patient with respiratory failure

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients who suffered from pneumonia and respiratory failure needed mechanical ventilator support with inform consent will be enrolled into study

You may qualify if:

  • Adults aged than 40 years old
  • Diagnosed as pneumonia
  • Respiratory failure with mechanical ventilator support

You may not qualify if:

  • Less than 40 years old
  • Has been treated with antibiotics more than 7 days within two weeks before enrolling into study
  • Suspected or active pulmonary tuberculosis infection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taichung Veterans General Hospital

Taichung, 40705, Taiwan

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Blood sample obtained for cytokines detection

MeSH Terms

Conditions

Pneumonia, BacterialRespiratory InsufficiencyPneumonia

Interventions

Defecation

Condition Hierarchy (Ancestors)

Bacterial InfectionsBacterial Infections and MycosesInfectionsRespiratory Tract InfectionsLung DiseasesRespiratory Tract DiseasesRespiration Disorders

Intervention Hierarchy (Ancestors)

Digestive System Physiological PhenomenaDigestive System and Oral Physiological Phenomena

Study Officials

  • Pin-Kuei Fu, MD, PhD

    Taichung Veterans General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, Department of Critical Care Medicine

Study Record Dates

First Submitted

December 14, 2017

First Posted

December 20, 2017

Study Start

August 28, 2017

Primary Completion

September 1, 2019

Study Completion

September 1, 2019

Last Updated

September 16, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will share

We will share study protocol and Informed Consent Form and Clinical Study Report to other researchers

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
One year after the study was completed
Access Criteria
E-mail to yetquen@gmail.com Dr. Pin-Kuei Fu

Locations